Literature DB >> 2393343

Migraine and psychopathology. Results of the Zurich cohort study of young adults.

K R Merikangas1, J Angst, H Isler.   

Abstract

We present data regarding the association of psychiatric syndromes and migraine headache from a prospective epidemiologic cohort study of 27- and 28-year-olds in Zurich, Switzerland. The prevalence of migraine of 13.3% approximates estimates from previous epidemiologic studies in other regions of the world. Consistent with previous reports, there was a strong association between migraine and depression. However, this is the first study to demonstrate this association in an unselected epidemiologic sample with standardized assessment of psychiatric diagnoses by direct interview. The association between migraine and the anxiety disorders was even stronger than that for the affective disorders. The combination of anxiety disorder and major depression, but not pure anxiety disorders, nor pure depression, were significantly associated with migraine. Our data suggest that migraine with anxiety and depression may constitute a distinct syndrome comprising anxiety, often manifested in early childhood, followed by the occurrence of migraine headaches, and then by discrete episodes of depressive disorder in adulthood. Because of the prospective longitudinal design of this study, future assessments of this cohort will provide further information on the stability of these findings and the course of this cohort as subjects proceed through adulthood.

Entities:  

Mesh:

Year:  1990        PMID: 2393343     DOI: 10.1001/archpsyc.1990.01810210057008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  98 in total

Review 1.  Psychiatric comorbidity in chronic daily headache: pathophysiology, etiology, and diagnosis.

Authors:  Vincenzo Guidetti; Federica Galli
Journal:  Curr Pain Headache Rep       Date:  2002-12

2.  Parent-child agreement in the reporting of headaches in a national sample of adolescents.

Authors:  Erin F Nakamura; Lihong Cui; Tarannum Lateef; Karin B Nelson; Kathleen R Merikangas
Journal:  J Child Neurol       Date:  2011-08-10       Impact factor: 1.987

Review 3.  Diagnosing migraine in the pediatric population.

Authors:  Paul Winner; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 4.  Childhood periodic syndromes and migraine.

Authors:  Paul Winner
Journal:  Curr Pain Headache Rep       Date:  2005-06

5.  Chronic Daily Headache: Theory to Therapy.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

6.  Gender differences, clinical correlates, and longitudinal outcome of bipolar disorder with comorbid migraine.

Authors:  Erika F H Saunders; Racha Nazir; Masoud Kamali; Kelly A Ryan; Simon Evans; Scott Langenecker; Alan J Gelenberg; Melvin G McInnis
Journal:  J Clin Psychiatry       Date:  2014-05       Impact factor: 4.384

Review 7.  Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulation.

Authors:  Kenneth Blum; Marcelo Febo; David E Smith; A Kenison Roy; Zsolt Demetrovics; Frans J Cronjé; John Femino; Gozde Agan; James L Fratantonio; Subhash C Pandey; Rajendra D Badgaiyan; Mark S Gold
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

8.  The Zurich Study: XXIII. Epidemiology of headache syndromes in the Zurich cohort study of young adults.

Authors:  K R Merikangas; A E Whitaker; H Isler; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

9.  Startle reactivity in children at risk for migraine.

Authors:  Roman Duncko; Lihong Cui; Jeffrey Hille; Christian Grillon; Kathleen R Merikangas
Journal:  Clin Neurophysiol       Date:  2008-10-31       Impact factor: 3.708

10.  A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT).

Authors:  M S Bayliss; J E Dewey; I Dunlap; A S Batenhorst; R Cady; M L Diamond; F Sheftell
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.